title: Attenuated pressor responses to amino acids in the rostral ventrolateral medulla after swimming training in conscious rats.
abstract: The cardiovascular effects of microinjection of the amino acids glutamate and glycine within the rostral ventrolateral medulla (RVLM) after swimming training (ST) in unrestrained awake rats were investigated. Unilateral microinjection of l-glutamate (5, 20 and 50 mM, in 100 nl) produced a dose dependent increase in mean arterial pressure (MAP) in control (C) (16+/-5 mm Hg; 29+/-6 mm Hg; 43+/-6 mm Hg) and swim (SW) (1+/-1 mm Hg; 16+/-2 mm Hg; 25+/-3 mm Hg) groups. However, the magnitude of this response was lower in the swim group. Prazosin injection produced hypotension and tachycardia in both groups (C=-43+/-3 mm Hg/98+/-16 bpm; SW=-61+/-5 mm Hg/115+/-32 bpm). In the SW group the hypotension caused by prazosin was greater compared to C group, but the tachycardia was not different between them. After prazosin, glutamate response in RVLM was blocked in both groups as well. When glycine (10 mM or 1 M, in 100 nl) were microinjected into the RVLM of C group we observed two different effects: decrease in MAP with the lower dose and an increase in MAP with the higher dose (10 mM=-13+/-2 mm Hg; 1 M=47+/-6 mm Hg). However, after ST the hypertensive response to glycine was blunted with no alterations in the hypotensive response (10 mM=-14+/-1 mm Hg; 1 M=18+/-4 mm Hg). These findings suggest that RVLM is involved in the modulation of the sympathetic outflow to the cardiovascular system during exercise training.
authors.affiliation: Department of Physiological Sciences, Center of Biological Sciences, State University of Londrina, Londrina, Paraná, Brazil. pinge@sercomtel.com.br
authors.forename: Marli Cardoso
authors.initials: MC
authors.lastname: Martins-Pinge
authors.forename: Lenice Kappes
authors.initials: LK
authors.lastname: Becker
authors.forename: Martha Regina Luccizano
authors.initials: MR
authors.lastname: Garcia
authors.forename: Daniel Breseguello
authors.initials: DB
authors.lastname: Zoccal
authors.forename: Renata Vasconcelos
authors.initials: RV
authors.lastname: Neto
authors.forename: Leonardo Salomão
authors.initials: LS
authors.lastname: Basso
authors.forename: Hugo Celso Dutra
authors.initials: HC
authors.lastname: de Souza
authors.forename: Oswaldo Ubríaco
authors.initials: OU
authors.lastname: Lopes
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D003243:Consciousness; D004305:Dose-Response Relationship, Drug; D018698:Glutamic Acid / Q000008:administration & dosage*; D005998:Glycine / Q000008:administration & dosage*; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000503:physiopathology; D007022:Hypotension / Q000503:physiopathology; D007276:Injections, Intraventricular; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects* / Q000502:physiology*; D008845:Microinjections; D010805:Physical Conditioning, Animal / Q000502:physiology*; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013550:Swimming / Q000502:physiology; D013610:Tachycardia / Q000503:physiopathology
chemical_list: D000959:Antihypertensive Agents; D018698:Glutamic Acid; D005998:Glycine; D011224:Prazosin